KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Newmont (NEM) Research & Development (2016 - 2025)

Newmont (NEM) has 14 years of Research & Development data on record, last reported at $43.0 million in Q4 2025.

  • For Q4 2025, Research & Development fell 10.42% year-over-year to $43.0 million; the TTM value through Dec 2025 reached $166.0 million, down 15.74%, while the annual FY2025 figure was $166.0 million, 15.74% down from the prior year.
  • Research & Development reached $43.0 million in Q4 2025 per NEM's latest filing, up from $40.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $80.0 million in Q3 2022 and bottomed at $31.0 million in Q1 2021.
  • Average Research & Development over 5 years is $47.3 million, with a median of $44.5 million recorded in 2022.
  • Peak YoY movement for Research & Development: surged 100.0% in 2022, then plummeted 33.75% in 2023.
  • A 5-year view of Research & Development shows it stood at $46.0 million in 2021, then skyrocketed by 30.43% to $60.0 million in 2022, then grew by 13.33% to $68.0 million in 2023, then decreased by 29.41% to $48.0 million in 2024, then fell by 10.42% to $43.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $43.0 million in Q4 2025, $40.0 million in Q3 2025, and $40.0 million in Q2 2025.